Silent killer, economic opportunity: rethinking non-communicable disease
Año de publicación: 2012
Non-communicable diseases (NCDs) are a major global
challenge, one that causes most of the deaths and disability
among humans.
These diseases are not transmissible from one person to
another. They include cardiovascular disease, cancer, chronic
respiratory disease, diabetes and mental health disorders, but
exclude injuries. Together, they caused 36 million deaths
in 2008, more than three out of five deaths worldwide, and
accounted for half of global disability. About one-quarter
of deaths occur before the age of 60, mainly in low- and
middle-income countries. Without preventive action, the
number of deaths under 60 in poor countries will rise from
3.8 million each year to 5.1 million by 2030.1
For low-income countries, the challenge of NCDs
compounds the difficulties of addressing infectious diseases,
creating a double burden that causes poverty and slows
development. The World Economic Forum predicts that
NCDs will result in a cumulative loss in global economic
output of $47 trillion, or 5% of GDP, by 2030, principally
through heart disease, stroke, alcohol misuse and depression in high-and upper-middle-income countries